| Primary |
| Benign Prostatic Hyperplasia |
39.2% |
| Product Used For Unknown Indication |
12.1% |
| Hypertension |
8.3% |
| Depression |
4.7% |
| Insomnia |
4.4% |
| Hypertonic Bladder |
3.8% |
| Prostatomegaly |
3.5% |
| Neurogenic Bladder |
2.5% |
| Urinary Tract Disorder |
2.5% |
| Urinary Tract Infection |
2.4% |
| Prostatism |
2.2% |
| Pollakiuria |
2.1% |
| Drug Use For Unknown Indication |
1.7% |
| Hypercholesterolaemia |
1.7% |
| Asthma |
1.6% |
| Cardiac Failure Chronic |
1.6% |
| Dysuria |
1.6% |
| Prostate Cancer |
1.5% |
| Blood Cholesterol Increased |
1.4% |
| Prostatic Disorder |
1.4% |
|
| Floppy Iris Syndrome |
11.6% |
| Urinary Retention |
10.2% |
| Syncope |
9.1% |
| Product Substitution Issue |
8.8% |
| Miosis |
8.1% |
| Drug Ineffective |
7.4% |
| Loss Of Consciousness |
4.6% |
| Dizziness |
4.2% |
| Hypotension |
4.2% |
| Orthostatic Hypotension |
3.9% |
| Atrial Fibrillation |
3.5% |
| Urticaria |
3.5% |
| Hyperthyroidism |
2.8% |
| Myocardial Infarction |
2.8% |
| Tremor |
2.8% |
| Vertigo |
2.8% |
| Colon Cancer |
2.5% |
| Convulsion |
2.5% |
| Dysuria |
2.5% |
| Hepatitis Fulminant |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
20.2% |
| Benign Prostatic Hyperplasia |
18.9% |
| Drug Use For Unknown Indication |
17.4% |
| Hypertension |
10.9% |
| Parkinson's Disease |
4.0% |
| Asthma |
3.7% |
| Depression |
3.0% |
| Hypertonic Bladder |
2.8% |
| Pollakiuria |
2.7% |
| Prostate Cancer |
2.6% |
| Diabetes Mellitus |
2.2% |
| Completed Suicide |
1.9% |
| Pain |
1.6% |
| Urinary Tract Infection |
1.6% |
| Erectile Dysfunction |
1.3% |
| Prostatomegaly |
1.2% |
| Urinary Tract Disorder |
1.1% |
| Dysuria |
1.0% |
| Blood Cholesterol Increased |
1.0% |
| Prophylaxis |
1.0% |
|
| Drug Ineffective |
9.2% |
| Hyperthyroidism |
7.2% |
| Syncope |
7.2% |
| Transient Ischaemic Attack |
7.2% |
| Orthostatic Hypotension |
6.6% |
| Completed Suicide |
5.9% |
| Interstitial Lung Disease |
5.3% |
| Urinary Retention |
5.3% |
| Cardiac Failure |
4.6% |
| Gynaecomastia |
4.6% |
| Atrial Fibrillation |
3.9% |
| Dizziness |
3.9% |
| Hypotension |
3.9% |
| Paranoia |
3.9% |
| Toxic Skin Eruption |
3.9% |
| Unresponsive To Stimuli |
3.9% |
| Benign Prostatic Hyperplasia |
3.3% |
| Drug Interaction |
3.3% |
| Insomnia |
3.3% |
| Loss Of Consciousness |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.5% |
| Drug Use For Unknown Indication |
13.7% |
| Hypertension |
9.8% |
| Benign Prostatic Hyperplasia |
6.0% |
| Prophylaxis |
3.7% |
| Diabetes Mellitus |
3.3% |
| Pain |
3.0% |
| Atrial Fibrillation |
2.6% |
| Prostate Cancer |
2.5% |
| Multiple Myeloma |
2.4% |
| Rheumatoid Arthritis |
2.3% |
| Insomnia |
2.2% |
| Constipation |
1.8% |
| Depression |
1.8% |
| Type 2 Diabetes Mellitus |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Non-small Cell Lung Cancer |
1.2% |
| Thrombosis Prophylaxis |
1.1% |
| Prostatic Disorder |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
|
| Pneumonia |
8.4% |
| Vomiting |
7.8% |
| Death |
6.7% |
| Weight Decreased |
6.7% |
| Sepsis |
5.7% |
| Thrombocytopenia |
5.3% |
| Renal Failure |
5.0% |
| Renal Failure Acute |
5.0% |
| Diarrhoea |
4.8% |
| Prostate Cancer |
4.6% |
| Urinary Tract Infection |
4.6% |
| Pyrexia |
4.5% |
| Dyspnoea |
4.1% |
| Drug Ineffective |
4.0% |
| Urinary Retention |
4.0% |
| Rhabdomyolysis |
3.9% |
| Somnolence |
3.8% |
| Syncope |
3.7% |
| Weight Increased |
3.7% |
| Hyperkalaemia |
3.6% |
|
| Interacting |
| Hypertension |
10.8% |
| Hypertonic Bladder |
10.8% |
| Ischaemic Cardiomyopathy |
10.8% |
| Benign Prostatic Hyperplasia |
8.1% |
| Cardiac Failure |
5.4% |
| Diabetes Mellitus |
5.4% |
| Erectile Dysfunction |
5.4% |
| Pain |
5.4% |
| Sleep Disorder |
5.4% |
| Urinary Tract Disorder |
5.4% |
| Arthritis |
2.7% |
| Back Disorder |
2.7% |
| Back Pain |
2.7% |
| Bladder Obstruction |
2.7% |
| Blood Cholesterol Increased |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.7% |
| Convulsion |
2.7% |
| Depression |
2.7% |
| Fibromyalgia |
2.7% |
| Gastrooesophageal Reflux Disease |
2.7% |
|
| Drug Interaction |
66.7% |
| Drug Administration Error |
8.3% |
| Loss Of Consciousness |
8.3% |
| Male Orgasmic Disorder |
8.3% |
| Syncope |
8.3% |
|
